Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $40.6B |
| FY2017, ended Dec 31, 2017 | $53.4B |
| FY2018, ended Dec 31, 2018 | $41.6B |
| FY2019, ended Dec 31, 2019 | $57.7B |
| FY2020, ended Dec 31, 2020 | $50.8B |
| FY2021, ended Dec 31, 2021 | $60.4B |
| FY2022, ended Dec 31, 2022 | $83.5B |
| FY2023, ended Dec 31, 2023 | $70.2B |
| FY2024, ended Dec 31, 2024 | $67.9B |
| FY2025, ended Dec 31, 2025 | $80.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $68.7B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $24.7B |
| FY2017, ended Dec 31, 2017 | $26.0B |
| FY2018, ended Dec 31, 2018 | $30.1B |
| FY2019, ended Dec 31, 2019 | $33.8B |
| FY2020, ended Dec 31, 2020 | $36.8B |
| FY2021, ended Dec 31, 2021 | $35.7B |
| FY2022, ended Dec 31, 2022 | $36.6B |
| FY2023, ended Dec 31, 2023 | $39.3B |
| FY2024, ended Dec 31, 2024 | $41.0B |
| FY2025, ended Dec 31, 2025 | $42.0B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $43.6B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.04B | $1.89B |
| FY2017, ended Dec 31, 2017 | $2.87B | $1.69B |
| FY2018, ended Dec 31, 2018 | $3.23B | $2.58B |
| FY2019, ended Dec 31, 2019 | $2.25B | $3.03B |
| FY2020, ended Dec 31, 2020 | $3.19B | $2.88B |
| FY2021, ended Dec 31, 2021 | $7.00B | $2.15B |
| FY2022, ended Dec 31, 2022 | $4.90B | $1.47B |
| FY2023, ended Dec 31, 2023 | $2.06B | $2.10B |
| FY2024, ended Dec 31, 2024 | $4.17B | $2.62B |
| FY2025, ended Dec 31, 2025 | $4.18B | $3.31B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $4.52B | $3.83B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.54B |
| FY2017, ended Dec 31, 2017 | $11.2B |
| FY2018, ended Dec 31, 2018 | $1.58B |
| FY2019, ended Dec 31, 2019 | $2.25B |
| FY2020, ended Dec 31, 2020 | $4.91B |
| FY2021, ended Dec 31, 2021 | $3.53B |
| FY2022, ended Dec 31, 2022 | $2.58B |
| FY2023, ended Dec 31, 2023 | $3.11B |
| FY2024, ended Dec 31, 2024 | $4.35B |
| FY2025, ended Dec 31, 2025 | $4.40B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.74B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.07B |
| FY2017, ended Dec 31, 2017 | $15.3B |
| FY2018, ended Dec 31, 2018 | $14.4B |
| FY2019, ended Dec 31, 2019 | $13.9B |
| FY2020, ended Dec 31, 2020 | $15.0B |
| FY2021, ended Dec 31, 2021 | $12.8B |
| FY2022, ended Dec 31, 2022 | $12.9B |
| FY2023, ended Dec 31, 2023 | $13.9B |
| FY2024, ended Dec 31, 2024 | $16.3B |
| FY2025, ended Dec 31, 2025 | $15.7B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $15.2B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 18.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 175M |
| FY2017, ended Dec 31, 2017 | 174M |
| FY2018, ended Dec 31, 2018 | 170M |
| FY2019, ended Dec 31, 2019 | 168M |
| FY2020, ended Dec 31, 2020 | 167M |
| FY2021, ended Dec 31, 2021 | 156M |
| FY2022, ended Dec 31, 2022 | 153M |
| FY2023, ended Dec 31, 2023 | 150M |
| FY2024, ended Dec 31, 2024 | 145M |
| FY2025, ended Dec 31, 2025 | 142M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 142M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.55B | $93.0M |
| FY2017, ended Dec 31, 2017 | $393M | $94.0M |
| FY2018, ended Dec 31, 2018 | $1.26B | $86.0M |
| FY2019, ended Dec 31, 2019 | $744M | $127M |
| FY2020, ended Dec 31, 2020 | $490M | $90.0M |
| FY2021, ended Dec 31, 2021 | $3.71B | $94.0M |
| FY2022, ended Dec 31, 2022 | $1.50B | $99.0M |
| FY2023, ended Dec 31, 2023 | $1.50B | $87.0M |
| FY2024, ended Dec 31, 2024 | $2.51B | $101M |
| FY2025, ended Dec 31, 2025 | $1.62B | $119M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $524M | $129M |
Valuation
At current price- Market Cap
- $78.3B
- P/E
- 17.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.8×
- Price / Book
- 4.2×
- EV / EBITDA
- 14.6×
Growth
Trailing 12 months- Revenue (TTM)
- $43.6B
- Revenue Growth YoY
- 6.5%
- Revenue CAGR 3Y
- 4.7%
- Revenue CAGR 5Y
- 2.7%
- EPS Growth YoY
- 14.1%
- Net Income Growth YoY
- 12.5%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 10.6%
- Net Margin
- 10.4%
- FCF Margin
- 8.8%
- Return on Equity
- 26.1%
Earnings
Trailing 12 months- Net Income
- $4.52B
- EPS (diluted)
- $31.68
- EBITDA
- $6.15B
- Operating Income
- $4.63B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $3.74B
- Total Debt
- $15.2B
- Net Debt
- $11.5B
- Total Assets
- $52.5B
- Total Liabilities
- $33.8B
- Shareholders' Equity
- $18.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.27B
- Capital Expenditure
- $1.44B
- Free Cash Flow
- $3.83B
Dividends and risk
Last 12 months- Dividend Yield
- 1.7%
- Dividend / Share
- $9.56
- Beta (5Y)
- -0.11
Every ratio is calculated from the company’s reported figures.